DCP

Davern Capital Partners Portfolio holdings

AUM $365M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$365M
AUM Growth
+$55.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$28.1M
2
+$19.2M
3
+$14.1M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$11.7M
5
GPCR icon
Structure Therapeutics
GPCR
+$8.65M

Top Sells

1
+$14M
2
+$11.9M
3
+$6.8M
4
CGON icon
CG Oncology
CGON
+$6.73M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.83M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$149B
$44.8M 12.28%
1,593,942
-448,300
REGN icon
2
Regeneron Pharmaceuticals
REGN
$65.8B
$34.6M 9.5%
44,800
-7,620
INSM icon
3
Insmed
INSM
$23.1B
$29.9M 8.19%
+182,562
IONS icon
4
Ionis Pharmaceuticals
IONS
$12.6B
$29.1M 7.97%
386,903
+148,426
NTRA icon
5
Natera
NTRA
$29.1B
$28.8M 7.9%
143,966
+65,316
BNTX icon
6
BioNTech
BNTX
$23.5B
$27.1M 7.44%
305,055
-66,161
ARGX icon
7
argenx
ARGX
$51B
$25.6M 7.02%
35,045
-640
LLY icon
8
Eli Lilly
LLY
$966B
$25.1M 6.88%
27,279
+18,972
RPRX icon
9
Royalty Pharma
RPRX
$23.9B
$24.9M 6.84%
520,009
-320,641
ROIV icon
10
Roivant Sciences
ROIV
$21.3B
$24.2M 6.64%
873,398
-154,900
LEGN icon
11
Legend Biotech
LEGN
$5.29B
$23.8M 6.52%
1,314,748
+258,080
MLYS icon
12
Mineralys Therapeutics
MLYS
$2.48B
$12.1M 3.32%
447,153
+236,505
ABVX
13
Abivax
ABVX
$10.3B
$8.7M 2.39%
78,125
+29,623
GENB
14
Generate Biomedicines
GENB
$1.68B
$7.4M 2.03%
+591,800
PRCT icon
15
Procept Biorobotics
PRCT
$1.51B
$6.53M 1.79%
+261,200
GPCR icon
16
Structure Therapeutics
GPCR
$2.81B
$6.1M 1.67%
+126,461
VRDN icon
17
Viridian Therapeutics
VRDN
$1.91B
$5.92M 1.62%
302,457
+40,842
CGON icon
18
CG Oncology
CGON
$5.36B
– –
-162,005